MedPath

Celecoxib add on therapy in drug naive depressed wome

Phase 3
Conditions
major depressive disorder.
Depressive episode
Registration Number
IRCT201009043106N3
Lead Sponsor
Pharmaceutical Sciences Branch of Islamic Azad university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

1. women experiencing first episode of depression according to DSM-IV-TR and the Hamilton rating scale (17 items) score was ranged from 18 to 36. 2. None of them had previously received antidepressant treatment. Exclusion criteria: 1. History of taking antidepressant medications. 2. Other psychiatric disorders. 3. Significant suicidal ideation. 4. lactation and pregnancy. 5. Liver and kidney dysfunction and cardiovascular disorders. 6. Drug abuse.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression severity. Timepoint: baseline, week 4 and week 8. Method of measurement: Hamilton Depression rating scale -17 items.;Anxiety severity. Timepoint: baseline, week 4 and week 8. Method of measurement: Hamilton Anxiety rating scale.
Secondary Outcome Measures
NameTimeMethod
General health level. Timepoint: baseline, week 4 and week 8. Method of measurement: General health questionnair-28.
© Copyright 2025. All Rights Reserved by MedPath